Colorcon and TruTag Technologies Enter into Development Agreement Targeting Authentication of Medicines

Colorcon and TruTag Technologies, Inc. today announced execution of a development agreement to enable on-dose verification technology for tablets by combining TruTag’s silica-based microtag authentication technology with Colorcon’s industry-leading expertise in film coating systems, modified release technologies and specialty excipients.

The benefits of this innovation include the ability to instantly and unequivocally authenticate products when suspect events occur and specifically addresses the problems of counterfeiting, product diversion, returns monitoring, quality control and product recalls in pharmaceuticals and nutraceuticals.

“On-dose authentication technology represents the next generation in pharmaceutical supplychain security by providing a powerful tool for tracking product from plant to patient,” said Kelly Boyer, General Manager, Film Coatings of Colorcon. “By seamlessly enabling authentication, these digitized coatings confirm the quality and origin of medicines thereby safeguarding both patients and brands. Colorcon continues to advance technologies and services to meet industry challenges with innovative solutions.”

“Colorcon brings a shared vision for bringing innovation to the pharmaceutical industry, said Michael Bartholomeusz, CEO of TruTag Technologies. “They are market leaders in the filmcoating space, and they have the caliber and reach to make intelligent coatings a new industry standard. We are thrilled to be working with them.”